Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00431015
Status:
COMPLETED
Last Update Posted:
2012-12-10
First Post:
2007-01-31
Brief Title:
Phase III Safety Study of IPI-504 in RelapsedRefractory Stage IIIb or Stage IV Non-small Cell Lung Cancer NSCLC
Sponsor:
Infinity Pharmaceuticals Inc
Organization:
Infinity Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-31
First Submit QC Date:
January 31 2007
Study First Post Date:
2007-02-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2012-12-06
Disp First Submit QC Date:
December 6 2012
Disp First Post Date:
2012-12-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2012-12-06
Last Update Post Date:
2012-12-10
Last Update Post Date Type:
ESTIMATED